Common Contracts

AMENDED AND RESTATED SECOND AMENDMENT TO LETTER AGREEMENT

Letter Agreement • February 28th, 2022 • Mirati Therapeutics, Inc. • Pharmaceutical preparations

• Contract Type
  Letter Agreement
• Filed
  February 28th, 2022
• Company
  Mirati Therapeutics, Inc.
• Industry
  Pharmaceutical preparations

This Amended and Restated Second Amendment to Letter Agreement (this “Amendment”) is entered into by Mirati Therapeutics, Inc., a Delaware corporation (the “Company”), and James Christensen, Ph.D. (“Employee” or “you”) and shall be effective as of September 20, 2021.

SECOND AMENDMENT TO LETTER AGREEMENT

Letter Agreement • May 6th, 2021 • Mirati Therapeutics, Inc. • Pharmaceutical preparations • California

• Contract Type
  Letter Agreement
• Filed
  May 6th, 2021
• Company
  Mirati Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  California

This Second Amendment to Letter Agreement (the “Amendment”) is entered into by Mirati Therapeutics, Inc., a Delaware corporation (the “Company”), and James Christensen, Ph.D. (“Employee”) and shall be effective as of December 31, 2020.

SECOND AMENDMENT TO LETTER AGREEMENT

Letter Agreement • May 6th, 2021 • Mirati Therapeutics, Inc. • Pharmaceutical preparations

• Contract Type
  Letter Agreement
• Filed
  May 6th, 2021
• Company
  Mirati Therapeutics, Inc.
• Industry
  Pharmaceutical preparations

This Second Amendment to Letter Agreement (the “Amendment”) is entered into by Mirati Therapeutics, Inc., a Delaware corporation (the “Company”), and Charles M. Baum, M.D. (“Employee”) and shall be effective as of December 31, 2020.